The clinical application of two newly developed lipid emulsions (solipid® 20% s and e) in critically ill patients

Transfusion Medicine and Hemotherapy

Volumn 23, Issue 1, 1996, Pages 8-12

  Widhalm, K ^a   Kohl, S ^a   Hammerle, A ^b  

^a Klinik für Kinderheilkunde   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Fat emulsions; Intensive care patients; Lecithins; Lipids; Phosphatidylcholines

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; LIPID; LIPID EMULSION; PHOSPHATIDYLCHOLINE; SOLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; DRUG THERAPY; FEMALE; HUMAN; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; CRITICAL CARE; DOUBLE-BLIND METHOD; FAT EMULSIONS, INTRAVENOUS; FEMALE; HUMANS; LIPIDS; LIVER FUNCTION TESTS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PARENTERAL NUTRITION, TOTAL; PROSPECTIVE STUDIES;

EID: 0029971692     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000223248     Document Type: Article

References (15)

1. Wretlind A: Parenteral nutrition, Surg Clin North Am 1978:58:1055-1070.
2. Widhalm K, Pakosta R: Precipitation with polyethylene glycol and density gradient ultracentrifugation compared for determinating high-density lipoprotein subclasses HDL2 and HDL3. Clin Chem 1991:37: 238-240.
3. Widhalm K, Maxa E, Zyman H: Effect of diet and exercise upon the cholesterol and triglyceride content of plasma lipoproteins in overweight children, Eur J Pediatr 1978;127:121-126.
4. The Lipid Research Clinics Program Epidemiology Committee: Plasma lipid distributions in selected North American populations: The lipid research clinics program prevalence study, Circulation 1979; 60:427-439.
5. Heiss G, Johnson NJ, Reiland S, Davis CE, Tyroler HA: The epidemiology of plasma high-density lipoprotein cholesterol levels: The lipid research clinics program prevalence study, Circulation 1980;62 (suppl 4):116-137.
6. Kostner GM: Biochemistry and pathophysiology of human plasma apolipoproteins; in Rossencu M, Widhalm K, Jarausch J (eds): Apoproteins in Lipid Disorders, Risk Assessment and Monitoring, Wien, Springer, 1991. p 5.
7. Förster H: Dosierungsbegrenzungen bei parenteraler Fettzufuhr, Dtsch Med Wochenschr 1980:105: 132-135.
8. Hallberg D, Hallgren B, Schuberth O, Wretlind A: Parenteral Nutrition: Goals and Achievements, Part I, Nutritional Support Services, 1982. vol 12. no 7. pp 15-24.
9. Druml W, Zadravcc S, Kerbl H, Grimm G, Schnee-weiss B: Intensivmedizinischer Einsatz einer neuen Fettemulsion, Infusionstherapie 1990;17:306-312.
10. Lindholm M: Besonderheiten von Kohlenhydraten and Fett in der parenteralen Ernährung schwer-kranker Patienten, Beitr Infusionsther Klin Ernähr, Basel, Karger, 1986. vol 13. pp 142-153.
11. Wolfram G, Eckart J, Zöllner N: Störungen des Lipoprotein- und Fettsäurenstoffwechsels bei Schwerverletzten, Klin Wochenschr 1980:58:1327-1337.
12. Kadowaki H, Patton GM, Robins SJ: Effect of phosphatidylcholine molecular species on the uptake of HDL triglycerides and cholesteryl esters by the liver, J Lipid Res 1993;34:180-189.
13. Williams KJ, Scanu AM: Uptake of endogenous cholesterol by a synthetic lipoprotein, Biochim Biophys Acta 1986:875:183-194.
14. Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice K, Gornbein J, Ament ME, Eckert CD: Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients, Gastroenterology 1992; 102: 1363-1370.
15. Roulet M, Wiesel PH, Pilet M, Chapuis G, Carpen-tier YA: Effects of intravenously infused egg phospholipids on lipid and lipoprotein metabolism in postoperative trauma, J Parenter Enteral Nutr 1993;107-122.